Advertisement
Screener

BioCorRx Inc. (BICX) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price

1.6 / 5 stars · 26/82 Roast Me

BioCorRx Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price

BioCorRx Inc. (BICX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $7.15 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2022-03-31

  • BioCorRx Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2021-03-31 was $7.49.
  • BioCorRx Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2019-03-31 was $20.00.
  • BioCorRx Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2021 was $7.15, a 52.33% decline from fiscal 2020.
  • BioCorRx Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2020 was $15.00, a 25.00% decline from fiscal 2019.
  • BioCorRx Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2019 was $20.00, a 100.00% increase from fiscal 2018.
  • BioCorRx Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2018 was $10.00.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month
2021-12-31$7.15
10-K · filed 2022-03-31
2021-09-30$7.49
10-Q · filed 2021-11-15
2021-06-30$7.49
10-Q · filed 2021-08-13
2021-03-31$7.49
10-Q · filed 2021-05-17
2020-12-31$15.00
10-K · filed 2022-03-31
2020-09-30$0.00
10-Q · filed 2020-11-16
2019-12-31$20.00
10-K · filed 2021-03-31
2019-09-30$25.00
10-Q · filed 2019-11-14
2019-06-30$20.00
10-Q · filed 2019-08-14
2019-03-31$20.00
10-Q · filed 2019-05-15
2018-12-31$10.00
10-K · filed 2020-03-30
2015-12-31-$0.10
10-K · filed 2017-04-13
2014-12-31-$1.00
10-Q · filed 2015-11-16